PET has dominated the amyloid imaging ring for several years now, but a preclinical study is showing some signs that SPECT could give PET a run for its money eventually, especially in translational research, according to a study published Dec. 4 in the Journal of Nuclear Medicine.

Another year, another fascinating RSNA annual meeting. The conference had a more festive feel than in years past, with RSNA 2014 kicking off the society’s 100th anniversary celebration.

Radiation doses during pediatric intervention procedures tend to be higher for younger patients and in the abdominal area, according to a recent study in the American Journal of Roentgetology.

CHICAGO—Despite suggested guidelines from a federal task force for women to wait until 50 years old to begin breast cancer screenings, one presentation at the annual meeting of the Radiological Society of North America (RSNA) argued that data clearly show more lives are saved when annual screenings begin at age 40. 

A protein that suppresses immune response could tell researchers how patients taking a novel cancer immunotherapy will fare, Yale officials announced Nov. 26. The discovery could predict immune response in the treatment of a wide variety of cancers.

Cambridge, Mass., based biomedical company Biogen Idec announced encouraging results of a phase II drug targeting amyloid in Alzheimer’s patients at a Deutsche Bank conference in Boston today.

Early detection of blood cancers may be getting a big push with the discovery of a pre-cancerous state of genetic mutation in lymphomas, leukemia, myelodysplastic syndrome and other blood diseases. The biomarker is easily detectable in peripheral blood samples, according to two major studies published online Nov. 26 in the New England Journal of Medicine.

Mammographic technologists play a significant role in a radiologist’s performance when it comes to screenings, according to a new study.